Laboratoire de Bioimagerie et Pathologies


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2009

16 février 2012

A. ABI-GERGES, W. RICHTER, F. LEFEBVRE, P. MATEO, A. VARIN, C. HEYMES, J.L. SAMUEL, C. LUGNIER, M. CONTI, R. FISCHMEISTER & G. VANDECASTEELE. Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals. Circ. Res. 105, 784-792, 2009 – IF 10.19

M. ACHOUR, G. FUHRMANN, M. ALHOSIN, P. RONDE, T. CHATAIGNEAU, M. MOUSLI, V.B. SCHINI-KERTH & C. BRONNER. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem. Biophys. Res. Commun. 390, 523-528, 2009 – IF 2.72

R.L. GONÇALVES, C. LUGNIER, T. KERAVIS, M.J. LOPES, F.A. FANTINI, M. SCHMITT, S.F. CORTES & V.S. LEMOS. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue. Eur. J. Pharmacol. 620, 78-83, 2009 – IF 2.59

A. HAMADI, T.B. DERAMAUDT, K. TAKEDA & P. RONDE. Src activation and translocation from focal adhesions to membrane ruffles contribute to formation of new adhesion sites. Cell. Mol. Life Sci. 66, 324-338, 2009 – IF 6.61

I.H. LELONG-REBEL, Y. PIEMONT, M. FABRE & G. REBEL. Mycobacterium avium-intracellulare contamination of mammalian cell cultures. In Vitro Cell. Dev. Biol.-Anim. 45, 75-90, 2009 – IF 1.07

S. MARTIN, E.C. COSSET, J. TERRAND, A. MAGLOTT, K. TAKEDA & M. DONTENWILL. Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha5beta1 integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha5beta1 integrin antagonist. Biochim. Biophys. Acta-Mol. Cell Res. 1793, 354-367, 2009 – IF 5.02

E. MARTINKOVA, M. DONTENWILL, E. FREI & M. STIBOROVA. Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells. Neuroendocrinol. Lett. 30 Suppl. 1, 60-66, 2009 – IF 1.40

N. NIEDERHOFFER, R. LEVY, E. SICK, P. ANDRE, G. COUPIN, Y. LOMBARD & J.P. GIES. Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses. Int. J. Immunopathol. Pharmacol. 22, 473-483, 2009 – IF 1.93

E. PENCREACH, E. GUERIN, C. NICOLET, I. LELONG-REBEL, A.C. VOEGELI, P. OUDET, A.K. LARSEN, M.P. GAUB & D. GUENOT. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis. Clin. Cancer Res. 15, 1297-1307, 2009 – IF 7.17

E. SCHAFFNER-RECKINGER, A. SALSMANN, N. DEBILI, J. BELLIS, J.R. DE MEY, W. VAINCHENKER, W.H. OUWEHAND & N. KIEFFER. Overexpression of the partially activated alpha(IIb)beta3D723H integrin salt bridge mutant downregulates RhoA activity and induces microtubule-dependent proplatelet-like extensions in Chinese hamster ovary cells. J. Thromb. Haemost. 7, 1207-1217, 2009 – IF 6.02

E. SICK, N. NIEDERHOFFER, K. TAKEDA, Y. LANDRY & J.P. GIES. Activation of CD47 receptors causes histamine secretion from mast cells. Cell. Mol. Life Sci. 66, 1271-1282, 2009 – IF 6.61

R. TAHSELDAR-ROUMIEH, T. KERAVIS, S. MAAROUF, H. JUSTINIANO, R. SABRA & C. LUGNIER. PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization. Int. J. Exp. Pathol. 90, 605-614, 2009 – IF 2.35

K. TAKEDA. Delivery of magic bullets : on the still rocky road to gene therapy. Br. J. Pharmacol. 157, 151-152, 2009 – IF 4.71

G. ZUBER, M. DONTENWILL & J.P. BEHR. Synthetic viruslike particles for targeted gene delivery to alphavbeta3 integrin-presenting endothelial cells. Mol. Pharm. 6, 1544-1552, 2009 – IF 5.76